Cargando…

An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss

BACKGROUND: Facial filler injection techniques that help decrease the risk of vascular occlusion are an important growing area of study. This study demonstrates a model of injecting fillers into a simulated bifurcated arterial system, using different sized needle gauges at a constant injection press...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Gabriel, Khonda, Meghana, Hsu, Tammy, Rivkin, Alexander, Frank, Konstantin, Fezza, John, Woodward, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499102/
https://www.ncbi.nlm.nih.gov/pubmed/37711726
http://dx.doi.org/10.1097/GOX.0000000000005270
_version_ 1785105647043346432
author Scott, Gabriel
Khonda, Meghana
Hsu, Tammy
Rivkin, Alexander
Frank, Konstantin
Fezza, John
Woodward, Julie
author_facet Scott, Gabriel
Khonda, Meghana
Hsu, Tammy
Rivkin, Alexander
Frank, Konstantin
Fezza, John
Woodward, Julie
author_sort Scott, Gabriel
collection PubMed
description BACKGROUND: Facial filler injection techniques that help decrease the risk of vascular occlusion are an important growing area of study. This study demonstrates a model of injecting fillers into a simulated bifurcated arterial system, using different sized needle gauges at a constant injection pressure. METHODS: Three facial fillers were injected into a bifurcated intravenous tubing with continuous irrigation at a constant pressure to simulate a vascular system. Videography was used to observe for retrograde flow through the simulated supratrochlear artery to the bifurcation point, where the filler was redirected by anterograde flow into the branch representing the ophthalmic artery. RESULTS: Filler injection with retrograde flow to the bifurcation occurred with all the 27G needle trials. In comparison, the 30G needle trials were only able to reach the bifurcation point in three of the nine trials. The average time to the bifurcation point with subsequent ophthalmic artery anterograde flow with the 27G and 30G needles were 8.44 (95% confidence interval ±2.06) and 33.33 (95% confidence interval ±16.56) seconds, respectively. CONCLUSIONS: Larger 27G needles consistently reached retrograde flow and the bifurcation point faster than 30G needles. This study suggests thinner needles may be less likely to cause retrograde occlusion.
format Online
Article
Text
id pubmed-10499102
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104991022023-09-14 An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss Scott, Gabriel Khonda, Meghana Hsu, Tammy Rivkin, Alexander Frank, Konstantin Fezza, John Woodward, Julie Plast Reconstr Surg Glob Open Cosmetic BACKGROUND: Facial filler injection techniques that help decrease the risk of vascular occlusion are an important growing area of study. This study demonstrates a model of injecting fillers into a simulated bifurcated arterial system, using different sized needle gauges at a constant injection pressure. METHODS: Three facial fillers were injected into a bifurcated intravenous tubing with continuous irrigation at a constant pressure to simulate a vascular system. Videography was used to observe for retrograde flow through the simulated supratrochlear artery to the bifurcation point, where the filler was redirected by anterograde flow into the branch representing the ophthalmic artery. RESULTS: Filler injection with retrograde flow to the bifurcation occurred with all the 27G needle trials. In comparison, the 30G needle trials were only able to reach the bifurcation point in three of the nine trials. The average time to the bifurcation point with subsequent ophthalmic artery anterograde flow with the 27G and 30G needles were 8.44 (95% confidence interval ±2.06) and 33.33 (95% confidence interval ±16.56) seconds, respectively. CONCLUSIONS: Larger 27G needles consistently reached retrograde flow and the bifurcation point faster than 30G needles. This study suggests thinner needles may be less likely to cause retrograde occlusion. Lippincott Williams & Wilkins 2023-09-13 /pmc/articles/PMC10499102/ /pubmed/37711726 http://dx.doi.org/10.1097/GOX.0000000000005270 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Cosmetic
Scott, Gabriel
Khonda, Meghana
Hsu, Tammy
Rivkin, Alexander
Frank, Konstantin
Fezza, John
Woodward, Julie
An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss
title An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss
title_full An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss
title_fullStr An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss
title_full_unstemmed An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss
title_short An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss
title_sort experimental model exhibiting anterograde and retrograde vascular occlusion of facial fillers to avoid vision loss
topic Cosmetic
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499102/
https://www.ncbi.nlm.nih.gov/pubmed/37711726
http://dx.doi.org/10.1097/GOX.0000000000005270
work_keys_str_mv AT scottgabriel anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT khondameghana anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT hsutammy anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT rivkinalexander anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT frankkonstantin anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT fezzajohn anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT woodwardjulie anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT scottgabriel experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT khondameghana experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT hsutammy experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT rivkinalexander experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT frankkonstantin experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT fezzajohn experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss
AT woodwardjulie experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss